Forte Biosciences
FBRX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Forte Biosciences(FBRX) predict that the EBIT is -22.44 M (-39.17%), Miss estimate;the EPS is -1.24 (+9.49%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.02B39.17%
-0.02B27.97%
-0.00B11.20%
EPSMiss expectations
-1.249.49%
-1.186713.38%
-0.05333.89%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf